Petros Pharmaceuticals Inc (PTPI)
0.6308
-0.05
(-7.25%)
USD |
NASDAQ |
Apr 24, 16:00
0.6308
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Revenue (TTM): 5.822M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.822M |
| September 30, 2023 | 6.985M |
| June 30, 2023 | 3.852M |
| March 31, 2023 | 6.045M |
| December 31, 2022 | 5.992M |
| September 30, 2022 | 4.327M |
| June 30, 2022 | 7.930M |
| Date | Value |
|---|---|
| March 31, 2022 | 6.201M |
| December 31, 2021 | 7.811M |
| September 30, 2021 | 11.61M |
| June 30, 2021 | 12.93M |
| March 31, 2021 | 11.84M |
| December 31, 2020 | 9.560M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.852M
Minimum
Jun 2023
12.93M
Maximum
Jun 2021
7.762M
Average
6.985M
Median
Sep 2023
Revenue (TTM) Benchmarks
| Avalo Therapeutics Inc | 1.925M |
| Spectral AI Inc | 18.86M |
| Imunon Inc | -- |
| Assembly Biosciences Inc | -- |
| iBio Inc | -- |